thiazoles has been researched along with biguanides in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.26) | 18.7374 |
1990's | 9 (23.68) | 18.2507 |
2000's | 25 (65.79) | 29.6817 |
2010's | 2 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barker, J; Brown, MR; Collier, PJ; Farrell, I; Gilbert, P | 1 |
Rosskamp, E | 1 |
Basu, UP; Bose, AN; Ghosh, SN | 1 |
van Haeften, TW; Wolffenbuttel, BH | 1 |
Melander, A | 1 |
Kawamori, R; Yoshii, H | 1 |
Sakamoto, N; Uno, T | 1 |
Inoue, I; Ishii, J | 1 |
Bethel, MA; Feinglos, MN | 1 |
Skyler, JS | 1 |
Hunabiki, A; Kasuga, M; Morita, S | 1 |
Akuzawa, S; Ito, H; Iwaoka, K; Kamato, T; Kiso, T; Miyata, K; Nagakura, Y; Naitoh, Y; Sakai, H; Suzuki, M; Yamaguchi, T; Yamano, M; Yuki, H | 1 |
Campbell, IW | 1 |
Hirsch, IB; White, JA | 1 |
Awad, J; Schindel, B; Schindel, Y | 1 |
Arlt, W; Auchus, RJ; Miller, WL | 1 |
Feinglos, MN; Luna, B | 1 |
Rybka, J | 1 |
Drexler, AJ; Robertson, C | 1 |
Beattie, P; Harrigan, RA; Nathan, MS | 1 |
Hotta, N | 1 |
Inzucchi, SE | 1 |
Holmboe, ES | 1 |
McCormick, M; Quinn, L | 1 |
Inzucchi, SE; Mayerson, AB | 1 |
Weissman, P | 1 |
Slocum, JM; Sosa, ME | 1 |
Langer, O | 1 |
Maruyama, T | 1 |
Mori, Y; Sekihara, H | 1 |
Kitaoka, H | 1 |
Levitt, O; Merlob, P; Stahl, B | 1 |
Kotake, H | 1 |
Sakura, H | 1 |
Basu, A; Kudva, YC; Zangeneh, F | 1 |
Cai, Y; Finsi, J; Heimberg, H; Hinke, SA; Martens, GA; Pipeleers, D; Van de Casteele, M | 1 |
Frenzel, E; Niederweis, M; Schmidt, S; Steinhauer, K | 1 |
Aldahmash, AM; Alkahtani, A; Alkahtany, SM; Anil, S; Elsafadi, MA; Mahmood, A | 1 |
28 review(s) available for thiazoles and biguanides
Article | Year |
---|---|
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Topics: Acarbose; Aldehyde Reductase; Biguanides; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Insulin; Lipids; Prospective Studies; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; United Kingdom | 1995 |
Oral antidiabetic drugs: an overview.
Topics: Biguanides; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Sulfonylurea Compounds; Thiazoles | 1996 |
[Drug therapy in subjects with impaired glucose tolerance].
Topics: Acarbose; Biguanides; Chromans; Diabetes Mellitus, Type 2; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin Resistance; Metformin; Pioglitazone; Risk Factors; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone | 1996 |
[Oral hypoglycemic agents--overview].
Topics: Acarbose; Administration, Oral; Biguanides; Chromans; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone | 1997 |
[Measures to meet the side effects of the orally administered antihyperglycemic drugs].
Topics: Acarbose; Administration, Oral; Animals; Biguanides; Cardiovascular System; Chromans; Drug Interactions; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Inositol; Insulin Resistance; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone | 1997 |
Treatment of type 2 diabetes mellitus.
Topics: Biguanides; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Diet, Diabetic; Exercise Therapy; Glycoside Hydrolase Inhibitors; Health Care Costs; Humans; Hypoglycemic Agents; Insulin; Patient Compliance; Patient Participation; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
[Etiology and therapy of insulin resistance].
Topics: Animals; Arteriosclerosis; Biguanides; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Obesity; Risk Factors; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 1999 |
Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?
Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Risk Factors; Thiazoles | 2000 |
Nonhypoglycemic drug reactions of agents used to treat diabetes.
Topics: Benzamides; Biguanides; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles | 2000 |
[Update on new oral treatment for diabetes].
Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incidence; Sulfonylurea Compounds; Thiazoles | 2001 |
Oral agents in the management of type 2 diabetes mellitus.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2001 |
[Current and future aspects of oral antidiabetic agents in type 2 diabetes].
Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2001 |
Type 2 diabetes. How new insights, new drugs are changing clinical practice.
Topics: Acarbose; Aged; Biguanides; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Thiazoles; Thiazolidinediones; Treatment Outcome | 2001 |
Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Topics: Administration, Oral; Benzoates; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Drug Interactions; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Metabolic Clearance Rate; Safety; Sulfonylurea Compounds; Thiazoles; Time Factors; Treatment Outcome | 2001 |
[Clinical difference between thiazolidinediones and biguanides].
Topics: Biguanides; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin Resistance; Thiazoles; Thiazolidinediones | 2001 |
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
Topics: Administration, Oral; Biguanides; Blood Glucose; Carbamates; Chromans; Diabetes Mellitus, Type 2; Diet; Drug Therapy, Combination; Enzyme Inhibitors; Exercise; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Piperidines; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Treatment of type 2 diabetes mellitus: pharmacologic intervention.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Type 2 diabetes therapy. A pathophysiologically based approach.
Topics: alpha-Glucosidases; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus.
Topics: Administration, Oral; Antihypertensive Agents; Biguanides; Diabetes Mellitus, Type 2; Glucosamine; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Sulfonylurea Compounds; Thiazoles | 2002 |
Use of antidiabetes agents in pregnancy: current practice and controversy.
Topics: Administration, Oral; Benzamides; Biguanides; Diabetes, Gestational; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Polycystic Ovary Syndrome; Pregnancy; Pregnancy in Diabetics; Sulfonylurea Compounds; Thiazoles | 2002 |
When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus.
Topics: Administration, Oral; Biguanides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetes, Gestational; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Practice Guidelines as Topic; Pregnancy; Sulfonylurea Compounds; Thiazoles; Treatment Failure | 2002 |
[Pharmacotherapies for type 1 diabetes mellitus].
Topics: Adjuvants, Immunologic; Animals; Biguanides; Chaperonin 60; Diabetes Mellitus, Type 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Niacinamide; Peptide Fragments; Peptides; Regeneration; Sulfonylurea Compounds; Thiazoles | 2002 |
[Adverse effects of oral hypoglycemic agents].
Topics: Acarbose; Administration, Oral; Biguanides; Cyclohexanes; Drug Interactions; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Nateglinide; Phenylalanine; Pioglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
[Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Topics: Acarbose; Animals; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Pioglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Oral antihyperglycemic agents during pregnancy and lactation: a review.
Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Lactation; Milk, Human; Pregnancy; Pregnancy in Diabetics; Pregnancy Outcome; Sulfonylurea Compounds; Thiazoles | 2002 |
[Syndrome X].
Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Leptin; Life Style; Metabolic Syndrome; Pioglitazone; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2002 |
[Combination therapy with biguanides].
Topics: Acarbose; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone | 2002 |
Insulin sensitizers.
Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Thiazoles; Thiazolidinediones | 2003 |
10 other study(ies) available for thiazoles and biguanides
Article | Year |
---|---|
Relationship between Legionella pneumophila and Acanthamoeba polyphaga: physiological status and susceptibility to chemical inactivation.
Topics: Acanthamoeba; Animals; Biguanides; Disinfectants; Drug Resistance; Iron; Legionella pneumophila; Thiazoles; Water Microbiology | 1992 |
[Toxicology of selected biocides].
Topics: Anti-Infective Agents, Local; Antifungal Agents; Biguanides; Chlorophenols; Cosmetics; Dichlorophen; Disinfectants; Hydrogen Peroxide; Oxazoles; Pharmaceutic Aids; Preservatives, Pharmaceutical; Thiazoles | 1987 |
Hypoglycaemic activity of some substituted thiazole and thiadiazole biguanides.
Topics: Animals; Biguanides; Blood Glucose; Female; Guinea Pigs; Male; Thiazoles | 1966 |
Targeted glycemic control in type 2 diabetes.
Topics: Aged; Algorithms; Anti-Obesity Agents; Biguanides; Blood Glucose; Blood Glucose Self-Monitoring; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1998 |
Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.
Topics: Acetylcholine; Action Potentials; Animals; Anthraquinones; Atrial Function; Biguanides; Binding, Competitive; Colon; Dinoprostone; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Muscle Contraction; Myocardial Contraction; Pyrroles; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Receptor Agonists; Thiazoles | 2000 |
Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase.
Topics: 3-Hydroxysteroid Dehydrogenases; Biguanides; Chromans; Cloning, Molecular; Humans; Kinetics; Metformin; Pioglitazone; Recombinant Proteins; Saccharomyces cerevisiae; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Oral antihyperglycemic therapy for type 2 diabetes: clinical applications.
Topics: Aged; Biguanides; Comorbidity; Decision Making; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Evidence-Based Medicine; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Patient Education as Topic; Patient Participation; Physician-Patient Relations; Practice Guidelines as Topic; Sulfonylurea Compounds; Thiazoles | 2002 |
Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biguanides; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Electron Transport; Electron Transport Complex I; Electron Transport Complex II; Enzyme Activation; Glucose; Hypoglycemic Agents; Insulin-Secreting Cells; Metformin; Mice; Mitochondria; Multienzyme Complexes; NADP; Oxidation-Reduction; Phenformin; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Succinates; Tetrazolium Salts; Thiazoles; Time Factors | 2007 |
Importance of porins for biocide efficacy against Mycobacterium smegmatis.
Topics: Biguanides; Disinfectants; Gene Deletion; Imines; Microbial Viability; Mycobacterium smegmatis; Oxazines; Oxazoles; Porins; Pyridines; Staining and Labeling; Thiazoles; Triazines; Xanthenes | 2011 |
Cytotoxicity of QMix™ endodontic irrigating solution on human bone marrow mesenchymal stem cells.
Topics: Acridine Orange; Biguanides; Cell Culture Techniques; Cell Death; Cell Line; Cell Membrane; Cell Shape; Cell Survival; Coloring Agents; Ethidium; Fluorescent Dyes; Humans; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Oxazines; Polymers; Root Canal Irrigants; Sodium Hypochlorite; Tetrazolium Salts; Thiazoles; Time Factors; Xanthenes | 2014 |